The companion animals drugs market, despite its substantial growth, faces several restraints that could impact its future development. These barriers primarily stem from economic, regulatory, and market dynamics that affect both the supply and demand for pet pharmaceuticals. One significant restraint is the high cost of veterinary care and medications. As specialized treatments and advanced drugs become more prevalent, the price of these medications can be prohibitive for some pet owners....